An interventional study of virtual reality in Symptom Cluster and Anxiety, sponsored by Dokuz Eylul University. Status unknown at 2 sites in Turkey. Open to participants aged 7 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-04-19.
Sponsored by Dokuz Eylul University · Not applicable, Interventional, and Supportive care
This study aim to evaluate the effect of virtual reality distraction on symptom management and anxiety in children aged 7-18 years with leukemia.
While the virtual reality initiative was applied to the children in the study group, no harm was given to the children in the control group. The virtual reality distraction method will not be applied to the control group. After the child and his family are informed about the study, their written informed consent will be obtained.
When the patients were admitted to the clinic the day before chemotherapy treatment was started, the symptom screening scale and anxiety scale will be applied.
Control Group: The researcher stated that no additional procedure will be applied to the children in the control group and that the symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.
VR group; A distraction intervention will be applied for 10-15 minutes once a day with VR glasses. The symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.
9,217 studies on the registry are indexed under Syndrome; 1,031 are open to participants now.
This study's planned enrollment of 40 is below the median of 50 across 6,515 interventional studies indexed under Syndrome.
Browse Syndrome studies →Dokuz Eylul University is the lead sponsor of 252 studies on the registry; 32 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
watching the application by wearing virtual glasses to the child during the 1st, 2nd and 3rd days of chemotherapy treatment
Device: virtual reality
no virtual reality distraction
virtual reality distraction
Change in symptom cluster
Symptom by Symptom Screening Tool(8-18) in SSPedi-Pediatric Patients with Cancer
Time frame: during the 1st, 2nd and 3rd days of chemotherapy treatment
Change in anxiety
anxiety by State-Trait Anxiety Inventory for Children
Time frame: (during the 1st, 2nd and 3rd days of chemotherapy treatment)
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dokuz Eylul University